Mark Rothera

President, Aegerion Pharmaceuticals, Inc.

Companies

Viracta Therapeutics, Inc.Board member Sep 19, 2022 to Mar 13, 2024¹
Viracta Therapeutics, Inc.Chief executive officer Sep 19, 2022 to Mar 13, 2024¹
Viracta Therapeutics, Inc.President Sep 19, 2022 to Mar 13, 2024¹
Orchard Therapeutics plcBoard member Jan 2, 2020 to Jan 2, 2020²
Orchard Therapeutics plcOfficer Jan 2, 2020 to Jan 2, 2020²
PTC TherapeuticsChief Commercial Officer Jun 19, 2013 to May 25, 2017³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Viracta Therapeutics, Inc.100,000 shares⁴Dec 1, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 1, 2023Bought 47,906 shares at $0.49 of Viracta Therapeutics, Inc.⁴
Nov 30, 2023Bought 52,094 shares at $0.49 of Viracta Therapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARViracta Therapeutics, Inc., Board member
2
SEC EDGAROrchard Therapeutics plc, Board member
3
SEC EDGARPTC Therapeutics, Chief Commercial Officer
4
SEC EDGARViracta Therapeutics, Inc. shares after the filing of Dec 1, 2023